Dry Eye

Showing NaN - NaN of 9

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Dry Eye Trial in United States (0.25% HL036 Ophthalmic Solution, Placebo)

Completed
  • Dry Eye
  • 0.25% HL036 Ophthalmic Solution
  • Placebo
  • Phoenix, Arizona
  • +9 more
Jan 4, 2023

Dry Eye Syndromes, Dry Eye Trial in United States (RGN-259, Placebo)

Completed
  • Dry Eye Syndromes
  • Dry Eye
  • Phoenix, Arizona
  • +19 more
May 2, 2022

Keratoconjunctivitis Sicca, Dry Eye Trial in United States (tavilermide ophthalmic solution, Placebo)

Completed
  • Keratoconjunctivitis Sicca
  • Dry Eye
  • tavilermide ophthalmic solution
  • Placebo
  • Phoenix, Arizona
  • +21 more
Oct 18, 2021

Blepharitis, Meibomianitis, Dry Eye Trial in United States (COL-101 (doxycycline, USP) capsules, )

Completed
  • Blepharitis
  • +2 more
  • COL-101 (doxycycline, USP) capsules
  • placebo
  • Little Rock, Arkansas
  • +7 more
Feb 16, 2021

Primary Sjögren Syndrome, Dry Eye Trial in United States (0.005% Lacripep, 0.01% Lacripep, Placebo)

Completed
  • Primary Sjögren Syndrome
  • Dry Eye
  • 0.005% Lacripep
  • +2 more
  • Birmingham, Alabama
  • +34 more
Jan 17, 2020

Dry Eye Trial in Louisville (Restylane Defyne)

Completed
  • Dry Eye
  • Restylane Defyne
  • Louisville, Kentucky
    The Eye Care Institute
Sep 5, 2019

Dry Eye Trial in United States (EBI-005, Placebo)

Unknown status
  • Dry Eye
  • Birmingham, Alabama
  • +11 more
Jun 2, 2015

Dry Eye Trial in United States (DE-110 ophthalmic suspension high dose, DE-110 ophthalmic suspension low dose, Placebo)

Completed
  • Dry Eye
  • DE-110 ophthalmic suspension high dose
  • +2 more
  • Inglewood, California
  • +13 more
May 19, 2014

Keratoconjunctivitis Sicca, Dry Eye Trial in United States (rebamipide 2% ophthalmic suspension, eye drops)

Completed
  • Keratoconjunctivitis Sicca
  • Dry Eye
  • rebamipide 2% ophthalmic suspension
  • placebo eye drops
  • Mesa, Arizona
  • +18 more
Jan 9, 2012